Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hermes Pharma is a leading specialized CDMO (Contract Development and Manufacturing Organization) focused on the development and production of user-friendly oral dosage forms. The company is renowned for its expertise in creating effervescent tablets, orally disintegrating granules (ODGs), chewable tablets, and lozenges, which are designed to enhance patient compliance and simplify medication intake. Their proprietary TOPO technology enables the stabilization of moisture-sensitive active pharmaceutical ingredients (APIs) through a specialized vacuum granulation process. Hermes Pharma offers a comprehensive suite of services, including formulation development, clinical trial manufacturing, and large-scale commercial production. As a division of Hermes Arzneimittel, the company leverages over a century of experience in the pharmaceutical and healthcare sectors to support global partners in the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hermes.